Aptose Biosciences Inc. (NASDAQ: APTO) today announced that it priced its previously announced underwritten public offering of 10,000,000 common shares ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE